Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.07
STJ's Cash-to-Debt is ranked lower than
94% of the 334 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. STJ: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
STJ' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.37 Max: No Debt
Current: 0.07
Equity-to-Asset 0.36
STJ's Equity-to-Asset is ranked lower than
84% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. STJ: 0.36 )
Ranked among companies with meaningful Equity-to-Asset only.
STJ' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.6 Max: 0.93
Current: 0.36
0.31
0.93
Interest Coverage 5.81
STJ's Interest Coverage is ranked lower than
82% of the 225 Companies
in the Global Medical Devices industry.

( Industry Median: 77.23 vs. STJ: 5.81 )
Ranked among companies with meaningful Interest Coverage only.
STJ' s Interest Coverage Range Over the Past 10 Years
Min: 5.81  Med: 15.5 Max: 24.41
Current: 5.81
5.81
24.41
Piotroski F-Score: 4
Altman Z-Score: 3.04
Beneish M-Score: -2.34
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 15.51
STJ's Operating Margin % is ranked higher than
81% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.31 vs. STJ: 15.51 )
Ranked among companies with meaningful Operating Margin % only.
STJ' s Operating Margin % Range Over the Past 10 Years
Min: 15.01  Med: 20.23 Max: 24.73
Current: 15.51
15.01
24.73
Net Margin % 11.05
STJ's Net Margin % is ranked higher than
77% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. STJ: 11.05 )
Ranked among companies with meaningful Net Margin % only.
STJ' s Net Margin % Range Over the Past 10 Years
Min: 8.09  Med: 15.34 Max: 17.82
Current: 11.05
8.09
17.82
ROE % 15.74
STJ's ROE % is ranked higher than
84% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. STJ: 15.74 )
Ranked among companies with meaningful ROE % only.
STJ' s ROE % Range Over the Past 10 Years
Min: 11.45  Med: 18.85 Max: 23.77
Current: 15.74
11.45
23.77
ROA % 5.33
STJ's ROA % is ranked higher than
69% of the 336 Companies
in the Global Medical Devices industry.

( Industry Median: 0.13 vs. STJ: 5.33 )
Ranked among companies with meaningful ROA % only.
STJ' s ROA % Range Over the Past 10 Years
Min: 5.33  Med: 9.57 Max: 12.8
Current: 5.33
5.33
12.8
ROC (Joel Greenblatt) % 33.13
STJ's ROC (Joel Greenblatt) % is ranked higher than
77% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. STJ: 33.13 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
STJ' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 33.13  Med: 41.7 Max: 55.1
Current: 33.13
33.13
55.1
3-Year Revenue Growth Rate 3.50
STJ's 3-Year Revenue Growth Rate is ranked lower than
55% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. STJ: 3.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
STJ' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 3.5  Med: 13.4 Max: 45
Current: 3.5
3.5
45
3-Year EBITDA Growth Rate 3.30
STJ's 3-Year EBITDA Growth Rate is ranked lower than
57% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 6.30 vs. STJ: 3.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
STJ' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -4.6  Med: 13.8 Max: 22.3
Current: 3.3
-4.6
22.3
3-Year EPS without NRI Growth Rate 8.70
STJ's 3-Year EPS without NRI Growth Rate is ranked higher than
59% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. STJ: 8.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
STJ' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -36.1  Med: 9 Max: 117.9
Current: 8.7
-36.1
117.9
GuruFocus has detected 9 Warning Signs with St Jude Medical Inc $STJ.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» STJ's 30-Y Financials

Financials (Next Earnings Date: 2017-10-19 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NYSE:EW, NYSE:ZBH, NYSE:SNN, NAS:ISRG, NAS:ALGN, OTCPK:SONVY, NYSE:VAR, NYSE:TFX, OTCPK:CNVVY, NYSE:BSX, OTCPK:CHEOY, OTCPK:WILLF, NAS:ABMD, NAS:MASI, OTCPK:GGNDF, NAS:IART, NAS:NUVA, OTCPK:EKTAY, NYSE:GMED, NAS:LIVN » details
Traded in other countries:JUD.Germany,
Headquarter Location:USA
St Jude Medical Inc develops, manufactures and distributes cardiovascular medical devices for global cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain.

St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an external clinician pro

Top Ranked Articles about St Jude Medical Inc

Abbott Labs Declares Quarterly Dividend Global health care company will pay its shareholders 26.5 cents per share
Abbott Laboratories (NYSE:ABT) announced a regular quarterly dividend of 26.5 cents per share June 9. Read more...
Mairs and Power Finds Value and Growth Close to Home This Minnesota-based firm tries to find companies based in the Upper Midwest so it can get to know them, have better access to management
Every guru finds a route to success, some unique edge in identifying reasonably priced companies that have more potential than average. Read more...
Abbott Laboratories Declares Quarterly Dividend Analysts' forecast increases for EPS and sales
Abbott Laboratories (NYSE:ABT) announced a regular quarterly dividend of 26.5 cents per share on Feb. 17. Read more...
FDA Approves Abbott Labs' Devices for MRI Scans Patients with Assurity MRI pacemaker or Tendril MRI pacing lead can have full-body scans
Good news for heart patients implanted with Abbott Labs’ (NYSE:ABT) Assurity MRI pacemaker and Tendril MRI pacing lead. The U.S. Food and Drug Administration (FDA) has approved the two devices for total-body MRI scans. Read more...
Abbott Closes St. Jude Medical Deal Wednesday The purchase will add to company's EPS in 2017
Abbott Labs (NYSE:ABT) communicated through the PRNewswire on Dec. 30 that the closure of the purchase of St. Jude Medical (NYSE:STJ) for $25 billion is expected on Wednesday. Read more...
Abbott Labs to Buy St. Jude Medical for $25 Billion Company agreed on US FTC conditions for the closing of the deal
Abbott Labs (NYSE:ABT) agreed Dec. 27 to the conditions imposed by the U.S. Federal Trade Commission for the closing of the deal that will see Abbott purchase St. Jude Medical (NYSE:STJ) for a total consideration of $25 billion. Read more...
Abbott Laboratories Announces Quarterly Dividend Health care company increased dividend by 1.9%
The board of Abbott Laboratories (NYSE:ABT) declared through PR Newswire Friday a dividend increase for the last quarter of the year. Read more...
Abbott Laboratories CEO Buys Stock in Company Insider invests in 369,950 shares in 5 separate transactions
Miles White (Insider Trades), CEO and chairman of Abbott Laboratories (ABT), purchased 369,950 shares in the company in five transations on Nov. 10. The per share price ranged from $40.45 to $40.67. Read more...
Richard Perry Exits AIG, Time Warner The investor's largest 3rd quarter sales
Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988. During the third quarter the guru’s largest sells were the following: Read more...
First Eagle Investment Management's Top 5 Stock Buys of 3rd Quarter Firm associated with legend Jean-Marie Eveillard reports portfolio positions
First Eagle, an investment firm managing around $100 billion, announced on Monday that its third-quarter trading activity included buying 26 new stocks. Read more...

Ratios

vs
industry
vs
history
PE Ratio 35.31
STJ's PE Ratio is ranked lower than
55% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 31.49 vs. STJ: 35.31 )
Ranked among companies with meaningful PE Ratio only.
STJ' s PE Ratio Range Over the Past 10 Years
Min: 12.69  Med: 21.26 Max: 38.28
Current: 35.31
12.69
38.28
Forward PE Ratio 18.48
STJ's Forward PE Ratio is ranked higher than
87% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. STJ: 18.48 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 35.31
STJ's PE Ratio without NRI is ranked lower than
56% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 31.49 vs. STJ: 35.31 )
Ranked among companies with meaningful PE Ratio without NRI only.
STJ' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.69  Med: 21.26 Max: 38.28
Current: 35.31
12.69
38.28
Price-to-Owner-Earnings 34.27
STJ's Price-to-Owner-Earnings is ranked higher than
52% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 37.06 vs. STJ: 34.27 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
STJ' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.98  Med: 21.96 Max: 136.33
Current: 34.27
10.98
136.33
PB Ratio 5.13
STJ's PB Ratio is ranked lower than
73% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.93 vs. STJ: 5.13 )
Ranked among companies with meaningful PB Ratio only.
STJ' s PB Ratio Range Over the Past 10 Years
Min: 2.13  Med: 3.94 Max: 6.27
Current: 5.13
2.13
6.27
PS Ratio 3.89
STJ's PS Ratio is ranked lower than
59% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 3.28 vs. STJ: 3.89 )
Ranked among companies with meaningful PS Ratio only.
STJ' s PS Ratio Range Over the Past 10 Years
Min: 1.85  Med: 3.14 Max: 4.77
Current: 3.89
1.85
4.77
Price-to-Free-Cash-Flow 27.61
STJ's Price-to-Free-Cash-Flow is ranked higher than
57% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 32.05 vs. STJ: 27.61 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
STJ' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.96  Med: 20.92 Max: 41.5
Current: 27.61
9.96
41.5
Price-to-Operating-Cash-Flow 21.26
STJ's Price-to-Operating-Cash-Flow is ranked lower than
54% of the 136 Companies
in the Global Medical Devices industry.

( Industry Median: 20.42 vs. STJ: 21.26 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
STJ' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.95  Med: 15 Max: 25.12
Current: 21.26
7.95
25.12
EV-to-EBIT 32.23
STJ's EV-to-EBIT is ranked lower than
63% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 24.65 vs. STJ: 32.23 )
Ranked among companies with meaningful EV-to-EBIT only.
STJ' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.1  Med: 19.2 Max: 34.2
Current: 32.23
10.1
34.2
EV-to-EBITDA 21.86
STJ's EV-to-EBITDA is ranked lower than
60% of the 186 Companies
in the Global Medical Devices industry.

( Industry Median: 18.57 vs. STJ: 21.86 )
Ranked among companies with meaningful EV-to-EBITDA only.
STJ' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.5  Med: 15.1 Max: 23.7
Current: 21.86
8.5
23.7
PEG Ratio 19.61
STJ's PEG Ratio is ranked lower than
91% of the 85 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. STJ: 19.61 )
Ranked among companies with meaningful PEG Ratio only.
STJ' s PEG Ratio Range Over the Past 10 Years
Min: 0.72  Med: 1.48 Max: 21.13
Current: 19.61
0.72
21.13
Shiller PE Ratio 31.89
STJ's Shiller PE Ratio is ranked higher than
75% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 47.60 vs. STJ: 31.89 )
Ranked among companies with meaningful Shiller PE Ratio only.
STJ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.41  Med: 30.82 Max: 57.55
Current: 31.89
17.41
57.55
Current Ratio 1.93
STJ's Current Ratio is ranked lower than
64% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. STJ: 1.93 )
Ranked among companies with meaningful Current Ratio only.
STJ' s Current Ratio Range Over the Past 10 Years
Min: 1.14  Med: 2.9 Max: 12.25
Current: 1.93
1.14
12.25
Quick Ratio 1.31
STJ's Quick Ratio is ranked lower than
70% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. STJ: 1.31 )
Ranked among companies with meaningful Quick Ratio only.
STJ' s Quick Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.06 Max: 11.45
Current: 1.31
0.86
11.45
Days Inventory 165.81
STJ's Days Inventory is ranked lower than
63% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. STJ: 165.81 )
Ranked among companies with meaningful Days Inventory only.
STJ' s Days Inventory Range Over the Past 10 Years
Min: 146.43  Med: 162.13 Max: 177.06
Current: 165.81
146.43
177.06
Days Sales Outstanding 79.05
STJ's Days Sales Outstanding is ranked lower than
60% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 68.69 vs. STJ: 79.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
STJ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 78.88  Med: 91.7 Max: 98.89
Current: 79.05
78.88
98.89
Days Payable 42.79
STJ's Days Payable is ranked lower than
66% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 55.39 vs. STJ: 42.79 )
Ranked among companies with meaningful Days Payable only.
STJ' s Days Payable Range Over the Past 10 Years
Min: 33.34  Med: 58.78 Max: 77.02
Current: 42.79
33.34
77.02

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.52
STJ's Dividend Yield % is ranked higher than
53% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. STJ: 1.52 )
Ranked among companies with meaningful Dividend Yield % only.
STJ' s Dividend Yield % Range Over the Past 10 Years
Min: 0.39  Med: 1.66 Max: 2.81
Current: 1.52
0.39
2.81
Dividend Payout Ratio 0.54
STJ's Dividend Payout Ratio is ranked lower than
54% of the 124 Companies
in the Global Medical Devices industry.

( Industry Median: 0.36 vs. STJ: 0.54 )
Ranked among companies with meaningful Dividend Payout Ratio only.
STJ' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.31  Med: 0.38 Max: 0.54
Current: 0.54
0.31
0.54
3-Year Dividend Growth Rate 8.00
STJ's 3-Year Dividend Growth Rate is ranked lower than
57% of the 79 Companies
in the Global Medical Devices industry.

( Industry Median: 10.20 vs. STJ: 8.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
STJ' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 8.7
Current: 8
0
8.7
Forward Dividend Yield % 1.53
STJ's Forward Dividend Yield % is ranked higher than
53% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 1.48 vs. STJ: 1.53 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.52
STJ's 5-Year Yield-on-Cost % is ranked lower than
56% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. STJ: 1.52 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
STJ' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.39  Med: 1.66 Max: 2.81
Current: 1.52
0.39
2.81
3-Year Average Share Buyback Ratio 1.50
STJ's 3-Year Average Share Buyback Ratio is ranked higher than
93% of the 230 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. STJ: 1.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STJ' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -9.1  Med: 0.6 Max: 4.2
Current: 1.5
-9.1
4.2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.79
STJ's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
67% of the 142 Companies
in the Global Medical Devices industry.

( Industry Median: 2.41 vs. STJ: 1.79 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
STJ' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.91  Med: 1.69 Max: 5.51
Current: 1.79
0.91
5.51
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.17
STJ's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
50% of the 28 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. STJ: 2.17 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.24
STJ's Price-to-Median-PS-Value is ranked lower than
64% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. STJ: 1.24 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
STJ' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61  Med: 1.23 Max: 4.09
Current: 1.24
0.61
4.09
Earnings Yield (Greenblatt) % 3.10
STJ's Earnings Yield (Greenblatt) % is ranked higher than
67% of the 334 Companies
in the Global Medical Devices industry.

( Industry Median: 1.12 vs. STJ: 3.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
STJ' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.9  Med: 5.2 Max: 9.9
Current: 3.1
2.9
9.9
Forward Rate of Return (Yacktman) % 6.95
STJ's Forward Rate of Return (Yacktman) % is ranked lower than
56% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 8.64 vs. STJ: 6.95 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
STJ' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 5.3  Med: 18.2 Max: 24.3
Current: 6.95
5.3
24.3

More Statistics

Revenue (TTM) (Mil) $5,956.00
EPS (TTM) $ 2.28
Short Percentage of Float2.41%
52-Week Range $48.83 - 84.00
Shares Outstanding (Mil)285.72

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 6,042 6,298 6,721
EPS ($) 4.03 4.36 4.81
EPS without NRI ($) 4.03 4.36 4.81
EPS Growth Rate
(Future 3Y To 5Y Estimate)
1.51%
Dividends per Share ($) 1.08 1.12 1.42
» More Articles for STJ

Headlines

Articles On GuruFocus.com
Motif Bio Announces Result of General Meeting and Total Voting Rights Jun 22 2017 
PNC Releases Results Of Annual Dodd-Frank Company-Run Stress Test Jun 22 2017 
Frank’s International N.V. to Participate in Upcoming Investor Conference Jun 22 2017 
M&T Bank Corporation Releases "Company-Run" Dodd-Frank Act Stress Test Results Jun 22 2017 
Western Gas To Present At Upcoming J.P. Morgan Energy Equity Investor Conference Jun 22 2017 
A Nation in Pain: Focus on Medicaid Jun 22 2017 
Proxy Advisory Firms Recommend Approval of ONEOK's and ONEOK Partners' Proposed Merger Transaction Jun 22 2017 
Sunoco LP Announces Bob Owens, President And Chief Executive Officer To Retire, Joe Kim Named Presid Jun 22 2017 
Pomerantz Law Firm Announces the Filing of a Class Action against Axiom Holdings, Inc. and Certain Jun 22 2017 
Tech Stocks Continue to Gain on Thursday Jun 22 2017 

More From Other Websites
Mairs and Power Finds Value and Growth Close to Home Jun 05 2017
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna May 23 2017
St. Jude Medical, Inc. -- Moody's withdraws St. Jude Medical's note ratings Mar 24 2017
Can Abbott Outperform Despite Alere? Mar 22 2017
Mairs & Power Growth Fund 4th Quarter Commentary Mar 16 2017
Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of... Mar 07 2017
Abbott Laboratories -- Moody's assigns Baa3 to Abbott's proposed exchange notes Feb 23 2017
Dept. of Homeland Security Provides A Timely Update On Abbott, St. Jude Feb 07 2017
Muddy Waters' Carson Block: Announced Tech Fixes Do Not Appear To Address Many Of The Larger... Jan 09 2017
St. Jude Medical, Inc. -- Moody's downgrades St. Jude Medical's note ratings; outlook stable Jan 05 2017
Abbott Laboratories -- Moody's downgrades Abbott's ratings to Baa3 from A2; outlook stable Jan 05 2017
IDEXX Laboratories Graduates to the S&P 500 Jan 04 2017
IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P... Jan 03 2017
Abbott Labs: Diagnosing Growth in 2017 Jan 03 2017
FDA Finalizes Cybersecurity Rules for Medical Devices Jan 03 2017
Abbott Closes St. Jude Medical Deal Wednesday Jan 03 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}